GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InspireMD Inc (FRA:II2) » Definitions » Cyclically Adjusted PB Ratio

InspireMD (FRA:II2) Cyclically Adjusted PB Ratio : 0.00 (As of May. 15, 2024)


View and export this data going back to 2016. Start your Free Trial

What is InspireMD Cyclically Adjusted PB Ratio?

As of today (2024-05-15), InspireMD's current share price is €2.22. InspireMD's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 was €2,523.89. InspireMD's Cyclically Adjusted PB Ratio for today is 0.00.

The historical rank and industry rank for InspireMD's Cyclically Adjusted PB Ratio or its related term are showing as below:

During the past years, InspireMD's highest Cyclically Adjusted PB Ratio was 0.02. The lowest was 0.01. And the median was 0.01.

FRA:II2's Cyclically Adjusted PB Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.2
* Ranked among companies with meaningful Cyclically Adjusted PB Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

InspireMD's adjusted book value per share data for the three months ended in Dec. 2023 was €1.658. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2,523.89 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


InspireMD Cyclically Adjusted PB Ratio Historical Data

The historical data trend for InspireMD's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InspireMD Cyclically Adjusted PB Ratio Chart

InspireMD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

InspireMD Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of InspireMD's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, InspireMD's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InspireMD's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InspireMD's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where InspireMD's Cyclically Adjusted PB Ratio falls into.



InspireMD Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

InspireMD's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.22/2523.89
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InspireMD's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, InspireMD's adjusted Book Value per Share data for the three months ended in Dec. 2023 was:

Adj_Book=Book Value per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=1.658/129.4194*129.4194
=1.658

Current CPI (Dec. 2023) = 129.4194.

InspireMD Quarterly Data

Book Value per Share CPI Adj_Book
201403 0.000 99.695 0.000
201406 0.000 100.560 0.000
201409 0.000 100.428 0.000
201412 0.000 99.070 0.000
201503 0.000 99.621 0.000
201506 0.000 100.684 0.000
201509 0.000 100.392 0.000
201512 0.000 99.792 0.000
201603 0.000 100.470 0.000
201606 0.000 101.688 0.000
201609 0.000 101.861 0.000
201612 0.000 101.863 0.000
201703 27,742.308 102.862 34,904.881
201706 18,250.000 103.349 22,853.649
201709 11,325.000 104.136 14,074.675
201712 1,163.636 104.011 1,447.894
201803 181.370 105.290 222.936
201806 407.907 106.317 496.545
201809 191.864 106.507 233.140
201812 150.332 105.998 183.550
201903 286.181 107.251 345.335
201906 52.963 108.070 63.426
201909 31.112 108.329 37.169
201912 18.558 108.420 22.152
202003 10.879 108.902 12.929
202006 5.276 108.767 6.278
202009 3.984 109.815 4.695
202012 3.044 109.897 3.585
202103 4.702 111.754 5.445
202106 4.282 114.631 4.834
202109 3.988 115.734 4.460
202112 3.577 117.630 3.936
202203 3.243 121.301 3.460
202206 2.926 125.017 3.029
202209 2.650 125.227 2.739
202212 1.971 125.222 2.037
202303 1.506 127.348 1.530
202306 2.039 128.729 2.050
202309 1.894 129.860 1.888
202312 1.658 129.419 1.658

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


InspireMD  (FRA:II2) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


InspireMD Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of InspireMD's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


InspireMD (FRA:II2) Business Description

Traded in Other Exchanges
Address
4 Menorat Hamaor Street, Tel Aviv, ISR, 6744832
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Germany, Italy, Belarus, Brazil, and other countries.

InspireMD (FRA:II2) Headlines

No Headlines